Hans Van Vlierberghe

Research interests

Publications

• Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

  The Lancet · 2023 · https://doi.org/10.1016/s0140-6736(23)01796-8

• Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches

  Cell · 2022 · https://doi.org/10.1016/j.cell.2021.12.018

• Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure

  Journal of Hepatology · 2020 · https://doi.org/10.1016/j.jhep.2020.07.046

• The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology

  Journal of Hepatology · 2020 · https://doi.org/10.1016/j.jhep.2020.06.013

• PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis

  Journal of Hepatology · 2020 · https://doi.org/10.1016/j.jhep.2020.11.019

• Osteopontin Expression Identifies a Subset of Recruited Macrophages Distinct from Kupffer Cells in the Fatty Liver

  Immunity · 2020 · https://doi.org/10.1016/j.immuni.2020.08.004

• Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial

  The Lancet Oncology · 2018 · https://doi.org/10.1016/s1470-2045(18)30351-6

• Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide

  Gastroenterology · 2018 · https://doi.org/10.1053/j.gastro.2018.12.005

• Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial

  The Lancet Infectious Diseases · 2016 · https://doi.org/10.1016/s1473-3099(16)00052-9

• The Liver May Act as a Firewall Mediating Mutualism Between the Host and Its Gut Commensal Microbiota

  Science Translational Medicine · 2014 · https://doi.org/10.1126/scitranslmed.3008618

• The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm

  Journal of Viral Hepatitis · 2014 · https://doi.org/10.1111/jvh.12248

• Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study

  The Lancet Oncology · 2012 · https://doi.org/10.1016/s1470-2045(12)70490-4

• Effects of Fractionated Plasma Separation and Adsorption on Survival in Patients With Acute-on-Chronic Liver Failure

  Gastroenterology · 2012 · https://doi.org/10.1053/j.gastro.2011.12.056

• Further Pharmacological and Genetic Evidence for the Efficacy of PlGF Inhibition in Cancer and Eye Disease

  Cell · 2010 · https://doi.org/10.1016/j.cell.2010.02.039

• Noninvasive diagnosis of liver cirrhosis using DNA sequencer–based total serum protein glycomics

  Nature Medicine · 2004 · https://doi.org/10.1038/nm1006

Current projects

No projects listed.